Literature DB >> 33974820

Building Toward Antiracist Cancer Research and Practice: The Case of Precision Medicine.

Jacob N Stein1,2, Marjory Charlot1, Samuel Cykert3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33974820      PMCID： PMC8257901          DOI： 10.1200/OP.20.01070

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN： 2688-1527


× No keyword cloud information.
  36 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Using community-based participatory research to address health disparities.

Authors:  Nina B Wallerstein; Bonnie Duran
Journal:  Health Promot Pract       Date:  2006-06-07

Review 3.  The value and challenges of participatory research: strengthening its practice.

Authors:  Margaret Cargo; Shawna L Mercer
Journal:  Annu Rev Public Health       Date:  2008       Impact factor: 21.981

4.  Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.

Authors:  Kenneth L Kehl; Christopher S Lathan; Bruce E Johnson; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2019-04-01       Impact factor: 13.506

5.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

Authors:  Brian O'Sullivan; Shao Hui Huang; Jie Su; Adam S Garden; Erich M Sturgis; Kristina Dahlstrom; Nancy Lee; Nadeem Riaz; Xin Pei; Shlomo A Koyfman; David Adelstein; Brian B Burkey; Jeppe Friborg; Claus A Kristensen; Anita B Gothelf; Frank Hoebers; Bernd Kremer; Ernst-Jan Speel; Daniel W Bowles; David Raben; Sana D Karam; Eugene Yu; Wei Xu
Journal:  Lancet Oncol       Date:  2016-02-27       Impact factor: 41.316

6.  Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.

Authors:  Jessica J Lin; Stephanie Cardarella; Christine A Lydon; Suzanne E Dahlberg; David M Jackman; Pasi A Jänne; Bruce E Johnson
Journal:  J Thorac Oncol       Date:  2015-12-25       Impact factor: 15.609

7.  Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients.

Authors:  Lauren L Palazzo; Deirdre F Sheehan; Angela C Tramontano; Chung Yin Kong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-20       Impact factor: 4.254

8.  Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.

Authors:  Michel D Wissing; Paul G Kluetz; Yang-Min Ning; Jonca Bull; Christine Merenda; Anthony J Murgo; Richard Pazdur
Journal:  Cancer       Date:  2014-06-25       Impact factor: 6.860

9.  The Effect of Advances in Lung-Cancer Treatment on Population Mortality.

Authors:  Nadia Howlader; Gonçalo Forjaz; Meghan J Mooradian; Rafael Meza; Chung Yin Kong; Kathleen A Cronin; Angela B Mariotto; Douglas R Lowy; Eric J Feuer
Journal:  N Engl J Med       Date:  2020-08-13       Impact factor: 91.245

10.  Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.

Authors:  Julie A Lynch; Brygida Berse; Merry Rabb; Paul Mosquin; Rob Chew; Suzanne L West; Nicole Coomer; Daniel Becker; John Kautter
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.